SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-18-000557
Filing Date
2018-06-07
Accepted
2018-06-07 19:23:36
Documents
1
Period of Report
2018-06-05

Document Format Files

Seq Description Document Type Size
1 AMENDED crispr-fm4a_jun72018.html 4/A  
1 AMENDED crispr-fm4a_jun72018.xml 4/A 3793
  Complete submission text file 0000905718-18-000557.txt   5139
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37923 | Film No.: 18887810

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)